Life sciences news
-
argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis
Thursday September 21st 2023
Read more
-
Galapagos appoints Simon Sturge to its Board of Directors
Tuesday September 19th 2023
Read more
-
13th Investment for HERAN Partners: Broken String Biosciences (UK)
Tuesday September 19th 2023
Read more
-
The QbD Group launches its new Business & Communications division
Monday September 18th 2023
Read more
-
AbolerIS Pharma announces €27 million in Series A financing to advance its novel treatment paradigm for autoimmune and inflammatory diseases
Sunday September 17th 2023
Read more
-
argenx announces positive CHMP opinion for subcutaneous efgartigimod for generalized myasthenia gravis
Friday September 15th 2023
Read more
-
New study discovers how neurons die in Alzheimer’s disease
Friday September 15th 2023
Read more
-
Augustine Therapeutics expands its leadership team and R&D platform, enters regulatory development
Tuesday September 12th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
SwiftPharma and the Population Council Pursue Agreement to Manufacture Griffithsin Needed for the Development of a Fast-Dissolving Insert for Protection Against HIV
Friday September 8th 2023
Read more
-
The QbD Group acquires life sciences consultancy Azierta to reinforce its global vigilance services and expand its presence in Spain
Tuesday September 5th 2023
Read more
-
SwiftPharma and AntoXa Corporation sign exclusive collaboration agreement to support the development and commercialization of a plant-made antibody against ricin exposure
Friday September 1st 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
